Medi Assist FY26 results: revenue up 25%, debt-free

What Medi Assist reported for Q4 and FY26

Medi Assist Healthcare Services Limited released its investor presentation for Q4 FY26 and FY26, outlining revenue growth, operating performance, and a stronger balance sheet. The company said it turned debt-free during FY26 and ended the year with a free cash position of ₹260.5 crore. Consolidated total income for FY26 stood at ₹923.2 crore, while operating revenue was ₹904.8 crore. Management also pointed to technology-led automation in claims processing and fraud detection as a key operational theme through the year. CEO and Whole Time Director Satish Gidugu described FY26 as a “milestone year”, noting AI-powered platforms processing close to one million claims each month.

FY26 top line: income and operating revenue

On a consolidated basis, Medi Assist reported FY26 total income of ₹923.2 crore, up 23.6% year-on-year. Operating revenue for FY26 was ₹904.8 crore, up 25.1% year-on-year. The company’s growth narrative also leaned on scale metrics in claims and premiums administered, alongside improvements in the company’s capital structure. In parallel, the release referenced audited results and related newspaper advertisements published on May 10, 2026 in Business Line and Navshakti under Regulation 47.

Q4 FY26 snapshot: margins and EBITDA

For Q4 FY26, consolidated total income was ₹243.2 crore, up 23.7% year-on-year. Operating revenue for the quarter came in at ₹242.0 crore, up 28.1% year-on-year. Q4 FY26 EBITDA was ₹48.3 crore, up 18.4% year-on-year. The EBITDA margin was reported at 19.9%, with the presentation noting a 132 bps improvement quarter-on-quarter. Another disclosure in the provided data set pegged Q4 EBITDA margin at 19.94% versus 21.60% in the year-ago quarter.

Profit after tax: reported, adjusted, and “steady-state” bridge

For FY26, Medi Assist reported PAT of ₹89.3 crore compared with ₹91.6 crore in FY25. Adjusted PAT, excluding exceptional items net of tax effect, was reported at ₹68.8 crore. Management also provided a “steady-state” PAT estimate of ₹98.0 crore, explaining a bridge from the reported PAT using normalization adjustments. These included a deferred tax liability (DTL) reversal of ₹32.0 crore related to the Paramount acquisition, exceptional items of ₹11.5 crore, and other normalization items totalling ₹23.1 crore. The company presented these figures as part of its commentary on underlying profitability and one-offs.

Key financial metrics table (Q4 and FY26)

Balance sheet: debt eliminated, net worth higher

One of the headline changes in FY26 was the company moving to a debt-free position. Medi Assist reported it eliminated a debt position of ₹150.1 crore from FY25. It also reported a free cash position of ₹260.5 crore and said net worth expanded to ₹852.4 crore. These balance sheet datapoints were positioned as a key outcome of the year, alongside operating execution.

Operating scale: claims processed, premiums administered, market share

In FY26, Medi Assist processed 10.0 million Group and Retail claims. The company provided a split of the claims handled during the year: 2.2 million cashless in-patient (IP) claims, 1.3 million reimbursement IP claims, 2.7 million cashless out-patient (OP) claims, and 3.8 million reimbursement OP claims. Group and Retail premiums administered stood at ₹25,923.2 crore, up 22.8% year-on-year. The company said overall Group and Retail market share reached 20.7%, up 115 bps year-on-year.

Segment notes: Group business remains largest contributor

The Group segment remained the largest revenue contributor, accounting for 69.5% of total revenue, up 11 bps. Group segment revenue was reported at ₹629.1 crore, up 25.3% year-on-year. Premiums managed in the Group segment were reported at ₹23,104 crore, up 25.6% year-on-year. The company also disclosed a Group market share of 33.7%, up 340 bps year-on-year.

Technology and fraud analytics: MAven Guard highlights

The company said its AI-powered Technology segment delivered 91.9% year-on-year revenue growth, indicating faster scaling in its technology-led offerings. It also stated that MAven Guard identified approximately ₹540 crore in health insurance fraud. The disclosure is notable because it links technology investments with measurable outcomes in claims oversight. However, the investor communication did not provide a revenue base figure for the Technology segment in the provided extracts.

Paramount acquisition and integration: migration to MAtrix

Medi Assist completed the acquisition of a 100% equity stake in Paramount Health Services and Insurance TPA Private Limited on July 1, 2025. The purchase consideration was ₹412.44 crore after closing adjustments. The company said the Paramount integration progressed, with 50%+ of PHS claims volume migrated to MAtrix as of April 2026. It added that MAtrix was on track to become the primary processing engine by Q2 FY27.

Dividend and corporate actions noted in the disclosures

The Board recommended a final dividend of ₹2 per share, as referenced in the results-related disclosures. The company also noted that during the quarter ended March 31, 2026, paid-up equity share capital increased from ₹35.261 crore to ₹37.305 crore. This was attributed to exercise of stock options by certain employees and the allotment of 385,863 equity shares and 3,701,000 equity shares through preferential allotment.

Stock data cited alongside the results

The provided text also included a market data snapshot stating Medi Assist Healthcare Services Ltd. share price moved up by 0.20% from its previous close of ₹462.00, with the stock last traded at ₹462.90. The same compilation referenced NSE: MEDIASSIST and BSE: 544088. As with all such snapshots, investors typically cross-check timing and context with exchange data.

Why the FY26 update matters for investors

The FY26 disclosures combine three investor-relevant threads: revenue growth, balance sheet strengthening, and operational scale. A move to debt-free status and a stated free cash position of ₹260.5 crore can change how the market evaluates financial risk and flexibility. Separately, the company’s claim-processing volumes and premiums administered provide a window into its positioning within the health insurance administration ecosystem. The Paramount migration milestones also matter because they indicate the pace of integration and operational standardisation across platforms.

Conclusion

Medi Assist’s FY26 presentation highlighted consolidated total income of ₹923.2 crore, operating revenue of ₹904.8 crore, and a debt-free balance sheet with ₹260.5 crore in free cash. The company also reported 10.0 million claims processed and ₹25,923.2 crore in premiums administered, alongside progress on the Paramount integration. Next key checkpoints flagged in the update include the MAtrix migration roadmap, with the platform targeted to become the primary processing engine by Q2 FY27.